Resistance management of Amivantamab

For patients who develop resistance to Amivantumab (Amivantamab), treatment options will be influenced by multiple factors, including the patient's specific circumstances, molecular characteristics of the tumor, history of previous treatment, and available treatment options. Resistance is often multifactorial, so combining evantumumab with other targeted therapies may be an effective approach. This may interfere with different resistance mechanisms and improve treatment efficacy. It is important to regularly check patients for disease progression and treatment response. If signs of drug resistance are found, doctors can adjust the treatment plan promptly.